Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

Undifferentiated nasopharyngeal carcinomas (NPCs) are commonly present with latent EBV infection. However, events regulating EBV infection at early stages of the disease and the role of EBV in disease pathogenesis are largely undefined. Genetic alterations leading to activation of cyclin D1 signaling in premalignant nasopharyngeal epithelial (NPE) cells have been postulated to predispose cells to EBV infection. We previously reported that loss of p16, a negative regulator of cyclin D1 signaling, is a frequent feature of NPC tumors. Here, we report that early premalignant lesions of nasopharyngeal epithelium overexpress cyclin D1. Furthermore, overexpression of cyclin D1 is closely associated with EBV infection. Therefore we investigated the potential role of cyclin D1 overexpression in dysplastic NPE cells in vitro. In human telomerase reverse transcriptase-immortalized NPE cells, overexpression of cyclin D1 or a p16-resistant form of CDK4 (CDK4R24C) suppressed differentiation. This suppression may have implications for the close association of EBV infection with undifferentiated NPC. In these in vitro models, we found that cellular growth arrest and senescence occurred in EBV-infected cell populations immediately after infection. Nevertheless, overexpression of cyclin D1 or a p16-resistant form of CDK4 or knockdown of p16 in the human telomerase reverse transcriptase-immortalized NPE cell lines could counteract the EBV-induced growth arrest and senescence. We conclude that dysregulated expression of cyclin D1 in NPE cells may contribute to NPC pathogenesis by enabling persistent infection of EBV.

[1]  L. Young,et al.  The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). , 2012, Seminars in cancer biology.

[2]  K. To,et al.  Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.

[3]  S. Tsao,et al.  The biology of EBV infection in human epithelial cells. , 2012, Seminars in cancer biology.

[4]  E. Kieff,et al.  Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression , 2011, Proceedings of the National Academy of Sciences.

[5]  S. Tsao,et al.  Epstein‐Barr virus infection in immortalized nasopharyngeal epithelial cells: Regulation of infection and phenotypic characterization , 2010, International journal of cancer.

[6]  Ke Xu,et al.  Influenza A Virus Replication Induces Cell Cycle Arrest in G0/G1 Phase , 2010, Journal of Virology.

[7]  M. Esteban,et al.  The interferon system and vaccinia virus evasion mechanisms. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[8]  Justin M. Richner,et al.  Host Shutoff Is a Conserved Phenotype of Gammaherpesvirus Infection and Is Orchestrated Exclusively from the Cytoplasm , 2009, Journal of Virology.

[9]  M. Rowe,et al.  Features Distinguishing Epstein-Barr Virus Infections of Epithelial Cells and B Cells: Viral Genome Expression, Genome Maintenance, and Genome Amplification , 2009, Journal of Virology.

[10]  Yen-Ju Chen,et al.  The Epstein-Barr virus replication and transcription activator, Rta/BRLF1, induces cellular senescence in epithelial cells , 2009, Cell cycle.

[11]  R. Rice,et al.  Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage‐deprivation in human keratinocytes , 2009, Journal of cellular biochemistry.

[12]  Baoying Liu,et al.  Human T-Cell Leukemia Virus Type 1 Infection Leads to Arrest in the G1 Phase of the Cell Cycle , 2008, Journal of Virology.

[13]  A. Nanbo,et al.  The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells , 2007, The EMBO journal.

[14]  M. Ressing,et al.  Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion , 2007, Proceedings of the National Academy of Sciences.

[15]  G. Klein,et al.  Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions , 2007, Oncogene.

[16]  P. Meltzer,et al.  Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.

[17]  H. Yoshiyama,et al.  Epstein-Barr Virus-Encoded Poly(A)− RNA Confers Resistance to Apoptosis Mediated through Fas by Blocking the PKR Pathway in Human Epithelial Intestine 407 Cells , 2005, Journal of Virology.

[18]  W. Kuo,et al.  Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. , 2005, Cancer research.

[19]  D. Thorley-Lawson,et al.  Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo , 2005, Journal of Virology.

[20]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[21]  S. Makino,et al.  Murine Coronavirus Replication Induces Cell Cycle Arrest in G0/G1 Phase , 2004, Journal of Virology.

[22]  Kwok Wai Lo,et al.  Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.

[23]  N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.

[24]  K. Lo,et al.  Genetic and epigenetic changes in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[25]  S. Tsao,et al.  The significance of LMP1 expression in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[26]  G. Niedobitek,et al.  Epstein-Barr virus replication in tongue epithelial cells. , 2002, The Journal of general virology.

[27]  C. Flaitz,et al.  Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo. , 2001, The Journal of infectious diseases.

[28]  M. Tiainen,et al.  Reconstitution of Cyclin D1-Associated Kinase Activity Drives Terminally Differentiated Cells into the Cell Cycle , 2001, Molecular and Cellular Biology.

[29]  L. Yoo,et al.  Determining the Role of the Epstein-Barr Virus Cp EBNA2-Dependent Enhancer during the Establishment of Latency by Using Mutant and Wild-Type Viruses Recovered from Cottontop Marmoset Lymphoblastoid Cell Lines , 2000, Journal of Virology.

[30]  L. Nicholson,et al.  Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells. , 1999, The Journal of general virology.

[31]  G. Niedobitek,et al.  Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. , 1996, Seminars in cancer biology.

[32]  E. Flemington,et al.  The Epstein‐Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin‐dependent kinase inhibitors. , 1996, The EMBO journal.

[33]  Kathryn Flynn,et al.  Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. , 1995, The New England journal of medicine.

[34]  D. Huang,et al.  p16 gene alterations in nasopharyngeal carcinoma. , 1995, Cancer research.

[35]  J. Bartek,et al.  Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Young,et al.  Epstein–Barr virus infection and replication in a human epithelial cell system , 1992, Nature.